We are live on ! Find out more
IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

37 hedge funds and large institutions have $8.67M invested in ImmunoCellular Therapeutics, Ltd. in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 14 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less capital invested

Capital invested by funds: $10.1M → $8.67M (-$1.46M)

24% less funds holding

Funds holding: 4937 (-12)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

71% less call options, than puts

Call options by funds: $724K | Put options by funds: $2.52M

79% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 14

Holders
37
Holders Change
-12
Holders Change %
-24.49%
% of All Funds
1.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
3
Reduced
14
Closed
19
Calls
$724K
Puts
$2.52M
Net Calls
-$1.8M
Net Calls Change
-$2.1M
Name Holding Trade Value Shares
Change
Change in
Stake
NSIM
51
North Star Investment Management
Illinois
-$39K -500 Closed
JP Morgan Chase
52
JP Morgan Chase
New York
-$34K -439 Closed
CAS
53
CTC Alternative Strategies
Illinois
-$29.5K -380 Closed
SG Americas Securities
54
SG Americas Securities
New York
-$25K -318 Closed
TCIM
55
TIAA CREF Investment Management
New York
-$19K -245 Closed
California Public Employees Retirement System
56
California Public Employees Retirement System
California
-$3K -45 Closed